{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:18:50Z","timestamp":1783131530351,"version":"3.54.6"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jtho.2021.01.1614","type":"journal-article","created":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T11:03:14Z","timestamp":1621681394000},"page":"e39-e41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Could Protons Promote Tumor Control by Avoiding Lymphopenia?"],"prefix":"10.1016","volume":"16","author":[{"given":"Eric","family":"Deutsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Cengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Galluzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonin","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2021.01.1614_bib1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1056\/NEJM195207312470506","article-title":"Control of the hydrogen ion","volume":"247","author":"Christensen","year":"1952","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtho.2021.01.1614_bib2","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1080\/0284186X.2020.1817977","article-title":"A\u00a0Nordic-Baltic perspective on indications for proton therapy with strategies for identification of proper patients","volume":"59","author":"Brandal","year":"2020","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jtho.2021.01.1614_bib3","article-title":"Intermediate dose-volume parameters, not low-dose bath, is superior to predict radiation pneumonitis for lung cancer treated with intensity-modulated radiotherapy","volume":"15","author":"Meng","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtho.2021.01.1614_bib4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.radonc.2019.09.017","article-title":"Cross-modality applicability of rectal normal tissue complication probability models from photon- to proton-based radiotherapy","volume":"142","author":"Pedersen","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jtho.2021.01.1614_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijrobp.2006.01.027","article-title":"Intensity-modulated radiation therapy, protons, and the risk of second cancers","volume":"65","author":"Hall","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtho.2021.01.1614_bib6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0167-8140(99)00079-1","article-title":"Risk assessment of radiation-induced malignancies based on whole-body equivalent dose estimates for IMRT treatment in the head and neck region","volume":"53","author":"Verellen","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jtho.2021.01.1614_bib7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41590-019-0561-4","article-title":"Immunological impact of cell death signaling driven by radiation on the tumor microenvironment","volume":"21","author":"Rodriguez-Ruiz","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jtho.2021.01.1614_bib8","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41591-018-0232-2","article-title":"Radiotherapy induces responses of lung cancer to CTLA-4 blockade","volume":"24","author":"Formenti","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jtho.2021.01.1614_bib9","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/s41590-020-0751-0","article-title":"Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy","volume":"21","author":"Yamazaki","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jtho.2021.01.1614_bib10","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1182\/blood-2009-02-206870","article-title":"Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment","volume":"114","author":"Lee","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtho.2021.01.1614_bib11","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.critrevonc.2012.09.001","article-title":"Radiation therapy and immunotherapy: implications for a combined cancer treatment","volume":"85","author":"Levy","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jtho.2021.01.1614_bib12","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/1878-0261.12658","article-title":"Radiotherapy-immunotherapy combinations\u2014perspectives and challenges","volume":"14","author":"Mondini","year":"2020","journal-title":"Mol Oncol"},{"key":"10.1016\/j.jtho.2021.01.1614_bib13","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1016\/S1470-2045(19)30171-8","article-title":"Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy","volume":"20","author":"Deutsch","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtho.2021.01.1614_bib14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejca.2016.03.067","article-title":"Can immunostimulatory agents enhance the abscopal effect of radiotherapy?","volume":"62","author":"Levy","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jtho.2021.01.1614_bib15","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1038\/s41467-019-11906-2","article-title":"Tumor-reprogrammed resident T cells resist radiation to control tumors","volume":"10","author":"Arina","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtho.2021.01.1614_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2018.12.002","article-title":"The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy","volume":"133","author":"Deng","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jtho.2021.01.1614_bib17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijrobp.2019.05.064","article-title":"Impact of radiation dose to the host immune system on tumor control and survival for stage III non-small cell lung cancer treated with definitive radiation therapy","volume":"105","author":"Ladbury","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtho.2021.01.1614_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.radonc.2019.12.023","article-title":"Lymphopenia during radiotherapy in patients with oropharyngeal cancer","volume":"145","author":"Ng","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jtho.2021.01.1614_bib19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijrobp.2018.09.010","article-title":"The impact of radiation therapy on lymphocyte count and survival in metastatic cancer patients receiving PD-1 immune checkpoint inhibitors","volume":"103","author":"Pike","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtho.2021.01.1614_bib20","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.jtho.2020.06.008","article-title":"Radiotherapy-related lymphopenia affects overall survival in patients with lung cancer","volume":"15","author":"Abravan","year":"2020","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2021.01.1614_bib21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.radonc.2020.12.019","article-title":"Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: a comparative analysis of proton versus photon therapy","volume":"156","author":"Kim","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jtho.2021.01.1614_bib22","first-page":"116","article-title":"In-vivo and in-vitro impact of high-dose rate radiotherapy using flattening-filter-free beams on the anti-tumor immune response","volume":"24","author":"Laurent","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.jtho.2021.01.1614_bib23","doi-asserted-by":"crossref","first-page":"11018","DOI":"10.1038\/s41598-020-67913-7","article-title":"Author correction: ultra high dose rate (35 Gy\/sec) radiation does not spare the normal tissue in cardiac and splenic models of lymphopenia and gastrointestinal syndrome","volume":"10","author":"Venkatesulu","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtho.2021.01.1614_bib24","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1158\/1078-0432.CCR-19-4155","article-title":"Methodological development of combination drug and radiotherapy in basic and clinical research","volume":"26","author":"Chargari","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2021.01.1614_bib25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2020.05.051","article-title":"Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy","volume":"150","author":"Chen","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jtho.2021.01.1614_bib26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ctrv.2016.03.001","article-title":"Optimize and refine therapeutic index in radiation therapy: overview of a century","volume":"45","author":"Chargari","year":"2016","journal-title":"Cancer Treat Rev"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086421016610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086421016610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:46:36Z","timestamp":1761561996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086421016610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1556086421016610"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2021.01.1614","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Could Protons Promote Tumor Control by Avoiding Lymphopenia?","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2021.01.1614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Association for the Study of Lung Cancer. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}